# Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination

> **NCT00143780** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 70 (—)

## Conditions studied

- Bone Marrow Transplant

## Interventions

- **BIOLOGICAL:** The polysaccharide vaccine used is Pneumovax (Merck vaccines)
- **BIOLOGICAL:** The conjugate vaccine used is Prevnar (Wyeth-Ayerst vaccines)

## Key facts

- **NCT ID:** NCT00143780
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 70 (—)
- **Last updated:** 2008-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143780, "Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00143780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*